COMPASS PATHWAYS PLC Income Taxes Paid
COMPASS PATHWAYS PLC (CMPS) reported Income Taxes Paid of $755.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-03-24
- COMPASS PATHWAYS PLC income taxes paid for fiscal 2025 was $755.00K, a 32.65% decline from fiscal 2024.
- COMPASS PATHWAYS PLC income taxes paid for fiscal 2024 was $1.12M, a 54.10% decline from fiscal 2023.
- COMPASS PATHWAYS PLC income taxes paid for fiscal 2023 was $2.44M.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2025-12-31 | $755.00K 10-K · filed 2026-03-24 |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-24 |
| 2023-12-31 | $2.44M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |